Project Grant H79TI084079
- Federal Project Grant Award Summary Tufts University School of Medicine received a $652,766 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective May 1, 2026, through February 28, 2031. The Extended-Release Opioid Use Disorder Treatment in Massachusetts (EXOUD-MASS) project will conduct research to optimize the integration of extended-release buprenorphine (XRB) formulations into the treatment landscape...
- The Beaufort County Health Department received a $999,865 Project Grant award from the Bureau of Justice Assistance (BJA) under the Comprehensive Opioid, Stimulant, and Substance Use Program (CFDA 16.838). The funding will support the expansion of the county's comprehensive program to combat the opioid epidemic, integrating medication-assisted treatment (MAT), behavioral health services, and harm reduction strategies, including syringe services. The MAT program will utilize the evidence-based...
- Federal Project Grant Award Summary The Northern Ohio Recovery Association (NORA) received a $1.125 million Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The award, effective September 30, 2025, through September 29, 2028, funds the expansion of mobile substance use disorder (SUD) and...
- This $1,599,999 Project Grant was awarded by the Bureau of Justice Assistance (BJA) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The award will expand and enhance Multnomah County's continuum of support for justice-involved individuals with opioid and other substance use disorders. Key activities and outcomes include: increasing medication-assisted treatment (MAT) initiation and maintenance between the county jail and community settings; providing...
- This Project Grant award of $896,785 from the U.S. Department of Justice's Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) supports the Hancock County, Mississippi Family Treatment Court to enhance services and improve equitable outcomes for families affected by substance use disorders. The key enhancements include: Expanding peer recovery support services by adding a certified peer support specialist to provide 40 hours per week of recovery services....
- Federal Grant Award Summary Stepworks Recovery Centers LLC received a $600,000 Project Grant from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912) for the period of September 1, 2025 through August 31, 2026. The StepWorks Assisting Detention Centers Bridge Clinic Project will establish a comprehensive opioid response and recovery support initiative in Breckinridge County, Kentucky, addressing substance use disorder (SUD) treatment gaps for...
- This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...
- Federal Grant Award Summary: BUP-BOOSTeR Boston University Medical Campus received a $2.9 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and optimize a multicomponent behavioral intervention designed to improve buprenorphine treatment retention for individuals with opioid use disorder. Awarded on September 30, 2025, with a completion date of May 31, 2030, the grant funds a clinical optimization...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
- Federal Grant Award Summary Friends Research Institute, Inc. received a $448,565 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective April 1, 2026, through March 31, 2027. The award supports a randomized controlled trial of Supporting Treatment for Opioids and Recovery Capital (STORC), a patient navigation intervention designed to enhance recovery outcomes for postpartum women with opioid use disorder (OUD)....
SUPPORTING OPIOID ADDICTION RECOVERY (SOAR) WILL PROVIDE MEDICATION-ASSISTED TREATMENT IN COMBINATION WITH PSYCHOSOCIAL AND RECOVERY SUPPORT SERVICES TO INDIVIDUALS WITH OPIOID USE DISORDER. - STEPPINGSTONE INCORPORATED'S (SS) SUPPORTING OPIOID ADDICTION RECOVERY (SOAR) PROPOSES TO PROVIDE MEDICATION-ASSISTED TREATMENT (MAT) IN GREATER NEW BEDFORD (NB) AND SURROUNDING RURAL AREAS TO INDIVIDUALS WITH AN OPIOID USE DISORDER (OUD), INCLUDING THOSE WITH A CO-OCCURRING MENTAL HEALTH DISORDER (COD). SPECIAL POPULATIONS TARGETED BY SOAR WILL INCLUDE PERSONS WITH CODS AND THE HISPANIC/LATINO POPULATION, PARTICULARLY THOSE WITH LIMITED ENGLISH PROFICIENCY (LEP). MAT WILL BE PROVIDED IN COMBINATION WITH COMPREHENSIVE PSYCHOSOCIAL AND RECOVERY SUPPORT SERVICES WHICH PROMOTE RECOVERY AND IMPROVED FUNCTIONING IN OTHER LIFE DOMAINS. SOAR WILL UTILIZE AN OUTREACH AND ENGAGEMENT WORKER AND RECOVERY COACHES, AS WELL AS COLLABORATION WITH THE NEW BEDFORD POLICE DEPARTMENT, GREATER NEW BEDFORD OPIOID TASK FORCE, AND GREATER NEW BEDFORD COMMUNITY HEALTH CENTER TO IDENTIFY INDIVIDUALS WITH OUD AND AT RISK OF OVERDOSE AND ENGAGE THEM IN MAT AND RECOVERY SUPPORT SERVICES. THROUGH OUTREACH AND MARKETING EFFORTS, SOAR WILL ENROLL AND SERVE 550 INDIVIDUALS OVER THE 5-YEAR GRANT TERM. ONCE ENROLLED, SOAR'S PSYCHIATRIST, NURSE PRACTITIONERS, MASTERS-LEVEL CLINICIANS AND RECOVERY COACHES WILL PROVIDE ONGOING TREATMENT AND INTERVENTIONS TO SUPPORT SUCCESSFUL RECOVERY AND PROMOTE AN IMPROVED QUALITY OF LIFE. PATIENTS WILL BE EVALUATED AND INDUCTED ON BUPRENORPHINE/NALOXONE OR ANOTHER TYPE OF MAT AS APPROPRIATE. NURSE PRACTITIONERS WILL CLOSELY MONITOR AND REGULARLY MEET WITH EACH SOAR PARTICIPANT TO ENSURE EFFECTIVENESS OF TREATMENT. SOAR CLINICIANS WILL PROVIDE COMPREHENSIVE OUD PSYCHOSOCIAL SERVICES UTILIZING EVIDENCE-BASED PRACTICES SUCH AS COGNITIVE BEHAVIORAL THERAPY, INTEGRATED TREATMENT FOR CO-OCCURRING DISORDERS, AND MOTIVATIONAL INTERVIEWING. SOAR WILL UTILIZE STEPPINGSTONE'S EXPANSIVE CONTINUUM OF CARE, AS WELL AS LINKAGE AGREEMENTS WITH A VARIETY OF LOCAL ORGANIZATIONS TO PROVIDE COMPREHENSIVE RECOVERY SUPPORT SERVICES SUCH AS REFERRAL TO PERMANENT HOUSING, EMPLOYMENT, EDUCATION, CHILDCARE, PRIMARY MEDICAL CARE, AND OTHER SERVICES AS NEEDED. SOAR STAFF WILL ALSO INCLUDE 1 FTE PROJECT DIRECTOR AND .25 FTE EVALUATOR. OTHER SERVICES WILL INCLUDE CRISIS CARE, RECOVERY PLANNING, INDEPENDENT LIVING SKILLS TRAINING, DISCHARGE PLANNING, AND ASSISTANCE OBTAINING ENTITLEMENTS AND EMPLOYMENT. THE GOALS OF PROJECT SOAR ARE TO EXPAND/ENHANCE ACCESS TO MAT FOR INDIVIDUALS WITH OUD, REDUCE OPIOID USE, MINIMIZE RISKS ASSOCIATED WITH OUD, AND PROMOTE TREATMENT ENGAGEMENT AND OTHER POSITIVE OUTCOMES BY INTEGRATING TREATMENT WITH RECOVERY SUPPORT SERVICES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 1/15/26 | ||
| Not listed | $0 | 1/13/26 | ||
| Not listed | $0 | 12/5/25 | ||
| Not listed | $0 | 12/5/25 | ||
| Not listed | $525.0k | 9/23/25 |